
8 ways China could help transform the global biopharma industry
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
The recent emergence of a thriving biopharmaceuticals industry in China is no longer just a China story. It is a global one, with profound implications for years to come.
For the past 15 years competitive intensity in the global biopharma market has increased markedly. Most recently, China has emerged as an important actor in the global biopharma ecosystem, adding a potent additional source of global biopharma innovation and disruption. What impact will this emergence of China have on the global industry?
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters